Cargando…
A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection
Understanding the mechanism of SARS‐CoV‐2 infection and identifying potential therapeutics are global imperatives. Using a quantitative systems pharmacology approach, we identified a set of repurposable and investigational drugs as potential therapeutics against COVID‐19. These were deduced from the...
Autores principales: | Chen, Fangyuan, Shi, Qingya, Pei, Fen, Vogt, Andreas, Porritt, Rebecca A, Garcia, Gustavo, Gomez, Angela C, Cheng, Mary Hongying, Schurdak, Mark E, Liu, Bing, Chan, Stephen Y, Arumugaswami, Vaithilingaraja, Stern, Andrew M, Taylor, D Lansing, Arditi, Moshe, Bahar, Ivet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328275/ https://www.ncbi.nlm.nih.gov/pubmed/34339582 http://dx.doi.org/10.15252/msb.202110239 |
Ejemplares similares
-
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
por: Cheng, Mary Hongying, et al.
Publicado: (2020) -
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
por: Cheng, Mary Hongying, et al.
Publicado: (2021) -
An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations
por: Cheng, Mary Hongying, et al.
Publicado: (2020) -
COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis
por: Noval Rivas, Magali, et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis
por: Noval Rivas, Magali, et al.
Publicado: (2022)